44 year old female presented with gum bleeding since 1 week. No organomegaly was seen. The hemogram revealed hemoglobin—100 g/L, total leucocyte count—4.2 × 109/L and platelet—1500 × 109/L. Previous counts, done 2 months back were normal. Peripheral smear showed marked thrombocytosis and 41% blasts with Auer rod (Fig. 1). Marrow showed similar blasts (47%). Megakaryocytes were adequate with bizarre morphology including large and hyper lobulated forms with some showing separated nuclei (Fig. 2). Maturing myeloid and erythroid components were seen without significant dysplasia. On immunophenotyping, the blasts were positive for MPO, CD34 (weak), CD117 and were negative for HLA-DR. Cytogenetics was normal (46, XX). Molecular genetic analysis showed mutation of NPM1 (by RT-PCR) with no FLT3-ITD (by RT-PCR) mutation. Subtyping of the NPM-1 mutation could not be done due to availability issue. Underlying myeloproliferative neoplasm(MPN) was excluded with negative result for BCR-ABL1 (by multiplex PCR), JAK2 (by ARMS-PCR), calreticulin and MPL mutation. Final diagnosis of acute myeloid leukemia (AML) with mutated NPM1 was made.
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.